%0 Journal Article
%T Usage of the levonorgestrel releasing intrauterine system in perimenopause.
%A Fait T
%J Ceska Gynekol
%V 89
%N 2
%D 2024
%M 38977378
暂无%R 10.48095/cccg2024156
%X Levonorgestrel releasing intrauterine system have excellent contraceptive efficacy with simultaneous lowering of menstruation's blood loss. It could be used for therapy of endometrial hyperplasia in perimenopause. In position of gestagen part of the hormone replacement therapy it has high control of endometrial proliferation. It is conjoined with the zero increasing of risk of thromboembolic disease in combination with transdermal oestrogen's application.